(Q33591509)

28 July 2017

1 reference

title

Conjugated polysaccharide vaccines (English)

1 reference

28 July 2017

1 reference

Ahmad H

1

1 reference

28 July 2017

Chapnick EK

series ordinal

2

1 reference

28 July 2017

publication date

1 March 1999

1 reference

Infectious Disease Clinics of North America

28 July 2017

published in

1 reference

28 July 2017

volume

13

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

113-33, vii

1 reference

Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: results from a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Neisseria meningitidis: vaccines and vaccine candidates

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

The immunogenicity of Haemophilus influenzae: meningococcal protein conjugate vaccine in Polynesian and non-Polynesian New Zealand infants

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Immunogenicity of meningococcal B polysaccharide conjugated to tetanus toxoid or CRM197 via adipic acid dihydrazide

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Role of pneumococcal surface protein A in the virulence of Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Antibodies against Haemophilus influenzae type b and tetanus in infants after subcutaneous vaccination with PRP-T/diphtheria, or PRP-OMP/diphtheria-tetanus vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Maternal and infant antibody response to meningococcal vaccination in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Bacterial meningitis in the United States in 1995. Active Surveillance Team

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Infant immunization with pneumococcal CRM197 vaccines: effect of saccharide size on immunogenicity and interactions with simultaneously administered vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Antibodies to poly[(2----8)-alpha-N-acetylneuraminic acid] and poly[(2----9)-alpha-N-acetylneuraminic acid] are elicited by immunization of mice with Escherichia coli K92 conjugates: potential vaccines for groups B and C meningococci and E. coli K1.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Experience in Finland with Haemophilus influenzae type b vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Invasive Haemophilus influenzae disease in adults. A prospective, population-based surveillance. CDC Meningitis Surveillance Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Prevention of respiratory infections in adults. Influenza and pneumococcal vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Vaccines for prevention of meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Preclinical evaluation of a novel group B meningococcal conjugate vaccine that elicits bactericidal activity in both mice and nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Immunogenicity and efficacy of Streptococcus pneumoniae polysaccharide-protein conjugate vaccines against homologous and heterologous serotypes in the chinchilla otitis media model

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Mucosal antibodies to Haemophilus influenzae type b capsular polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Zidovudine improves response to pneumococcal vaccine among persons with AIDS and AIDS-related complex

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Immune Response of Human Infants to Polysaccharide Vaccines of Groups A and C Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Human immunity to the meningococcus. I. The role of humoral antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

MF59 adjuvant enhances antibody responses of infant baboons immunized with Haemophilus influenzae type b and Neisseria meningitidis group C oligosaccharide-CRM197 conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Enhanced antibody responses in infants given different sequences of heterogeneous Haemophilus influenzae type b conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Six newly recognized types of Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

The pneumococcal vaccine after 15 years of use.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

N-propionylated group B meningococcal polysaccharide mimics a unique epitope on group B Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Phase I study of the immunogenicity and safety of conjugated Hemophilus influenzae type b vaccines in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Pneumococcal Polysaccharide-Meningococcal Outer Membrane Protein Complex Conjugate Vaccine Is Immunogenic in Infants and Children

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Comparison of the safety and immunogenicity of a pneumococcal conjugate with a licensed polysaccharide vaccine in human immunodeficiency virus and non-human immunodeficiency virus-infected children.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Patients with Igg subclass and/or selective antibody deficiency to polysaccharide antigens: initiation of a controlled clinical trial of intravenous immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Pilot trial of a pentavalent pneumococcal polysaccharide/protein conjugate vaccine in Gambian infants

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Comparative efficacy of pneumococcal neuraminidase and pneumolysin as immunogens protective against Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

The changing epidemiology of invasive bacterial infections in Massachusetts children, 1984 through 1991

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

A study of the pneumococcal vaccine in prevention of clinically acute atttacks of recurrent otitis media.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Antibody responses to polysaccharide and polysaccharide-conjugate vaccines after treatment of Hodgkin disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Capsular types of Streptococcus pneumoniae isolated from blood and CSF during 1982-1987

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Meningococcal antibody titres in infants of women immunised with meningococcal polysaccharide vaccine during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Molecular analysis of the pathogenicity of Streptococcus pneumoniae: the role of pneumococcal proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Pneumococcal conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Vaccine antigen interactions after a combination diphtheria-tetanus toxoid-acellular pertussis/purified capsular polysaccharide of Haemophilus influenzae type b-tetanus toxoid vaccine in two-, four- and six-month-old infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Administration of combined diphtheria and tetanus toxoids and pertussis vaccine, hepatitis B vaccine, and Haemophilus influenzae type b (Hib) vaccine to infants and response to a booster dose of Hib conjugate vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Evaluation of a pentavalent conjugated pneumococcal vaccine in toddlers

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Molecular size characterization of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Immunoglobulin G antibody responses to polyvalent pneumococcal vaccine in children in the highlands of Papua New Guinea.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Antibody response to unconjugated Haemophilus influenzae b and pneumococcal polysaccharide vaccines in children with recurrent infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Combination of DTP and Haemophilus influenzae type b conjugate vaccines can affect laboratory evaluation of potency and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Interaction of Haemophilus influenzae type b conjugate vaccines with diphtheria-tetanus-pertussis vaccine in control tests

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Evaluating the Haemophilus influenzae type b conjugate vaccine PRP-D

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Controlled trial of Haemophilus influenzae type B diphtheria toxoid conjugate combined with diphtheria, tetanus and pertussis vaccines, in 18-month-old children, including comparison of arm versus thigh injection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children--implications for vaccine strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Activation of virus replication after vaccination of HIV-1-infected individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Thymus-independent and thymus-dependent responses to polysaccharide antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Antibody responses to Haemophilus influenzae type B vaccines in men with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

An avidin-biotin based ELISA for quantitation of antibody to bacterial polysaccharides.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Response of recent human immunodeficiency virus seroconverters to the pneumococcal polysaccharide vaccine and Haemophilus influenzae type b conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Immunization policies and vaccine coverage among adults. The risk for missed opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970046-5

7 January 2021

10.1016/S0891-5520(05)70046-5

Identifiers

DOI

1 reference

28 July 2017

1 reference